Last €6.40 EUR
Change Today +0.005 / 0.08%
Volume 0.0
MD6B On Other Exchanges
Symbol
Exchange
London
Frankfurt
As of 2:09 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

md medical group invest-regs (MD6B) Snapshot

Open
€6.31
Previous Close
€6.40
Day High
€6.40
Day Low
€6.31
52 Week High
08/22/13 - €11.67
52 Week Low
04/29/14 - €3.54
Market Cap
481.0M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
75.1M
EX-Date
05/21/14
P/E TM
--
Dividend
€0.07
Dividend Yield
0.80%
Current Stock Chart for MD MEDICAL GROUP INVEST-REGS (MD6B)

Related News

No related news articles were found.

md medical group invest-regs (MD6B) Related Businessweek News

No Related Businessweek News Found

md medical group invest-regs (MD6B) Details

MD Medical Group Investments Plc, an investment holding company, operates in the healthcare industry. The company operates a chain of clinics that provide women’s and children’s healthcare services in Russia. It offers a range of services in various fields, including obstetrics and gynaecology, fertility and in vitro fertilization treatment, and paediatrics. The company also provides other services, such as dental care, laboratory examination, surgery, traumatology, and rehabilitation services, as well as diagnostics and consulting, and stem cell storage services; rents properties; and retails pharmaceutics. It operates 17 modern medical centres, which include 2 hospitals and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara Region, Irkutsk, and Yaroslavl; and 3 outpatient clinics that are operated by franchise partners in Kyiv. The company was incorporated in 2010 and is based in Limassol, Cyprus. MD Medical Group Investments Plc is a subsidiary of MD Medical Holding Limited.

3,118 Employees
Last Reported Date: 03/17/14
Founded in 2010

md medical group invest-regs (MD6B) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

md medical group invest-regs (MD6B) Key Developments

MD Medical Group Investments plc Reports Operating Results for the First Quarter of 2014

MD Medical Group Investments Plc reported operating results for the first quarter of 2014. For the period, the company reported the total number of deliveries increased by 16% year-on-year to 1,003 (despite a 2.4% y-o-y decrease in number of deliveries in Moscow during the period). Lapino hospital was the key driver of growth in deliveries. The total number of IVF cycles increased by 67% year-on-year, reaching 1,603. The like-for-like 1 (LFL) number of IVF cycles was up 26% year-on-year, with the contribution coming from clinics in St. Petersburg and Moscow. The total number of in-patient treatments in first quarter of 2014 grew by 26% year-on-year to 8,107. On a LFL basis, the number of in-patient treatments grew by 17% year-on-year and amounted to 7,533. The total number of out-patient treatments increased by 75% year-on-year and amounted to 192,342. On a LFL basis, out-patient admissions grew by 29% to 141,911.

MD Medical Group Investments Plc to Report Q1, 2014 Operating Results on Apr 22, 2014

MD Medical Group Investments Plc announced that they will report Q1, 2014 operating results on Apr 22, 2014

MD Medical Group Investments plc Reports Audited Consolidated Earnings Results for the Second Half Year and Full Year Ended December 31, 2013; Recommends Dividend for 2013

MD Medical Group Investments Plc reported audited consolidated earnings results for the second half year and full year ended December 31, 2013. For the year, revenue increased 40% to RUB 5,673 million against RUB 4,061 million for the same period in the last year, supported in particular by the continued ramp up at Lapino and newly acquired clinics. EBITDA for the year amounted to RUB 1,586 million against RUB 1,694 million for the same period in the last year. Total CAPEX increased by 16% and amounted to RUB 3,080 million RUB in 2013 due to M&A deals in Samara and Irkutsk which accounted for RIB 648 million, against RUB 2,646 million in 2012. For the second half year, the company reported revenue of RUB 3,095, EBITDA of RUB 941 million, and CAPEX of RUB 1,679 million. The Board of Directors has recommended a dividend for 2013 of USD 0.07 per share, representing 30% of net profit attributable to owners of the company. The record date and payment date for the aforementioned dividend will be announced on March 26, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MD6B:GR €6.40 EUR +0.005

MD6B Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MD6B.
View Industry Companies
 

Industry Analysis

MD6B

Industry Average

Valuation MD6B Industry Range
Price/Earnings 35.0x
Price/Sales 3.9x
Price/Book 2.5x
Price/Cash Flow 34.9x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MD MEDICAL GROUP INVEST-REGS, please visit www.mcclinics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.